Thus, repression of Aldh1a3 expression in PCs by these (and other) CKD mediators is a plausible mechanism for the repressed RA/RAR signaling pathway in PCs in this complex, but clinically relevant, CKD murine model. Here, RARA is linked to chronic kidney disease.